文献速递创伤与烧伤重症综合管理与镇静镇痛

创伤后早期警报素高迁移率族蛋白B1双相释放预测不良临床结局

Biphasic Release of the Alarmin High Mobility Group Box 1 Protein Early After Trauma Predicts Poor Clinical Outcome.
PubMed 文献 · Crit Care Med · 2019-01-01
一句话结论创伤后3-6小时出现第二波高迁移率族蛋白B1高峰的患者,其高迁移率族蛋白B1浓度是预测不良结局的最重要因素。

这项前瞻性单中心观察性研究在136例创伤患者中,用酶联免疫吸附法重复检测血浆总高迁移率族蛋白B1水平,以无呼吸机天数为主要结局。研究识别出两个不同的高迁移率族蛋白B1释放阶段:初始指数衰减相半衰期26分钟,与结局无关;第二波在伤后3-6小时达峰,见于伤情最重和生理紊乱最明显的患者,在多变量模型中始终是结局的最重要预测因素,使其他预测变量均不显著,仅年龄、性别和入院碱剩余对最大肌酐浓度有较小贡献。作者认为,伤后3-6小时高迁移率族蛋白B1浓度高的患者可能从高迁移率族蛋白B1特异性拮抗剂治疗中获益。

要点

  • 创伤后高迁移率族蛋白B1呈双相释放,初始相半衰期26分钟,与结局无关。
  • 第二波高迁移率族蛋白B1在伤后3-6小时达峰,见于伤情最重和生理紊乱最明显的患者。
  • 多变量模型中,第二波高迁移率族蛋白B1是结局的最重要预测因素,其他预测变量均不显著。
  • 仅年龄、性别和入院碱剩余对最大肌酐浓度有较小贡献。
  • 作者认为,伤后3-6小时高迁移率族蛋白B1浓度高的患者可能从高迁移率族蛋白B1特异性拮抗剂治疗中获益。

适用人群与场景

  • 便利招募的136例创伤患者,来自大学医院一级创伤中心。

研究设计与关键结果

  • 前瞻性单中心观察性研究, convenience recruitment 136例创伤患者,无干预。
  • 用酶联免疫吸附法重复检测血浆总高迁移率族蛋白B1水平,以无呼吸机天数为主要结局。
  • 识别出两个高迁移率族蛋白B1释放阶段:初始指数衰减相半衰期26分钟,与结局无关。
  • 第二波高迁移率族蛋白B1在伤后3-6小时达峰,见于伤情最重和生理紊乱最明显的患者,在多变量模型中始终是结局的最重要预测因素,使其他预测变量均不显著,仅年龄、性别和入院碱剩余对最大肌酐浓度有较小贡献。

证据类型、等级与局限

  • 证据类型:前瞻性单中心观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,伤后3-6小时高迁移率族蛋白B1浓度高的患者可能从高迁移率族蛋白B1特异性拮抗剂治疗中获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: The causal role of the prototype alarmin high mobility group box 1 protein in systemic inflammation and remote organ injury after trauma and shock is established in animal models but not in humans. Our aim was therefore to determine high mobility group box 1 protein concentration kinetics with high time resolution during the first hours after trauma in individual patients and investigate the association with outcome.

DESIGN: Prospective single-center observational study.

SETTING: University hospital Level I trauma center.

PATIENTS: Convenience recruitment of 136 trauma patients.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Total plasma high mobility group box 1 protein levels were analyzed with enzyme-linked immunosorbent assay in repeated samples. Relationships between predefined predictor variables and outcome were examined in multivariable linear regression models. Ventilator-free days was used as primary outcome measure. Two distinct high mobility group box 1 protein release phases were identified. An initial exponential decay phase with half-life 26 minutes was not correlated with outcome. In contrast, a second high mobility group box 1 protein wave peaking 3-6 hours after trauma in the most severely injured and physiologically deranged patients was consistently the most important predictor of outcome in our multivariable models, rendering all other predictor variables insignificant except for smaller contributions from age and sex, and of admission base excess for maximal creatinine concentration.

CONCLUSIONS: High mobility group box 1 protein was released in two consecutive phases. Only the second high mobility group box 1 protein wave was a significant predictor of outcome. Patients with a high high mobility group box 1 protein concentration between 3 and 6 hours after trauma might hypothetically benefit from high mobility group box 1 protein-specific antagonist therapy.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Ottestad W, Rognes IN, Pischke SE, et al. Biphasic Release of the Alarmin High Mobility Group Box 1 Protein Early After Trauma Predicts Poor Clinical Outcome. Crit Care Med. 2019. PMID: 31162203. doi:10.1097/CCM.0000000000003800

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。